TNF receptors regulate vascular homeostasis in zebrafish through a caspase-8, caspase-2 and P53 apoptotic program that bypasses caspase-3 by Espín, Raquel et al.
INTRODUCTION
Tumor necrosis factor-α (TNFα) is a powerful pro-inflammatory
cytokine produced and released mainly by mononuclear phagocytes
that regulates endothelial cell functions and strongly and specifically
alters their gene expression profile (Miura et al., 2006). TNFα exerts
its functions through interaction with two specific cell surface
receptors: the 55 kDa tumor necrosis factor receptor superfamily
member 1A (TNFRSF1A) and the 75 kDa TNFRSF1B (Shalaby et
al., 1990). TNFRSF1A is expressed in most cell types, even in
transformed cells, whereas TNFRSF1B function seems to be
restricted to immune and endothelial cells (Aggarwal, 2003). Recent
studies with deficient mice have shown that TNFRSF1A
predominantly triggers apoptosis or inflammation, whereas
TNFRSF1B promotes tissue repair and regeneration (Aggarwal,
2003). Neither TNFRSF1A nor TNFRSF1B has intrinsic enzymatic
activity, so they both need to recruit accessory proteins for signal
transduction. Three main types of proteins interact with the
cytoplasmic domains of TNFRs: TNFR-associated factors (TRAFs),
FAS-associated via death domains (FADDs) and TNFR-associated
via death domains (TRADDs). TNFRSF1A promotes the
recruitment of TRAF2 and TRADD, which interact with several
signaling proteins, such as the E3-ubiquitin ligases BIRC2 (cIAP1)
and BIRC3 (cIAP2), to form complex I. This complex induces the
proteasome-dependent degradation of the nuclear factor-κB (NF-
κB) inhibitor IκB and, hence, nuclear translocation of NF-κB and
the transcription of pro-inflammatory and survival genes (Locksley
et al., 2001; MacEwan, 2002). A complex II can also be generated
from complex I upon release from TNFRSF1A and recruitment of
FADD and caspase-8, resulting in caspase-8 activation and leading
to cell death (Locksley et al., 2001; MacEwan, 2002). By contrast,
TNFRSF1B triggers the recruitment of TRAF1 and TRAF2, which
interact with BIRC2 and BIRC3 (Rothe et al., 1995), leading to NF-
κB activation.
Therefore, TNFα has been dubbed a ‘double-edged sword’
because it might initiate distinct or overlapping signal transduction
pathways by binding to TNFRSF1A and/or TNFRSF1B, resulting
in a variety of cellular responses, such as survival, differentiation,
proliferation and migration, or, on the other hand, cell death
(Aggarwal, 2003). This pleiotropic activity links TNFα with a wide
variety of human diseases, including inflammatory and
autoimmune disorders, ischemia-reperfusion injury and cancer.
Using a forward genetic approach in the zebrafish (Danio rerio),
Santoro and co-workers identified BIRC2 as an essential molecule
involved in maintaining endothelial cell survival and vascular
homeostasis (Santoro et al., 2007). In the absence of BIRC2, a
caspase-8- and caspase-3-dependent apoptotic program leads to
vessel regression. Given that human BIRC2 plays a key role in the
TNFRSF1B signaling pathway (Rothe et al., 1995) and that
endothelial cells have been reported to be a major target for TNFα
in fish (Roca et al., 2008), we used gain- and loss-of-function studies
to analyze the role played by each TNFR in the development and
maintenance of endothelial cells in this species. We found that
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SUMMARY
Although it is known that tumor necrosis factor receptor (TNFR) signaling plays a crucial role in vascular integrity and homeostasis, the contribution
of each receptor to these processes and the signaling pathway involved are still largely unknown. Here, we show that targeted gene knockdown
of TNFRSF1B in zebrafish embryos results in the induction of a caspase-8, caspase-2 and P53-dependent apoptotic program in endothelial cells that
bypasses caspase-3. Furthermore, the simultaneous depletion of TNFRSF1A or the activation of NF-κB rescue endothelial cell apoptosis, indicating
that a signaling balance between both TNFRs is required for endothelial cell integrity. In endothelial cells, TNFRSF1A signals apoptosis through
caspase-8, whereas TNFRSF1B signals survival via NF-κB. Similarly, TNFα promotes the apoptosis of human endothelial cells through TNFRSF1A and
triggers caspase-2 and P53 activation. We have identified an evolutionarily conserved apoptotic pathway involved in vascular homeostasis that
provides new therapeutic targets for the control of inflammation- and tumor-driven angiogenesis.
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targeted gene silencing of TNFRSF1B results in the induction of a
caspase-8-dependent apoptotic program in endothelial cells that
can be rescued by depletion of TNFRSF1A. This indicates that an
appropriate signaling balance between both TNFRs is required for
endothelial cell integrity and vascular homeostasis. In addition, the
data also showed that, in endothelial cells, TNFRSF1A signals
apoptosis through complex II formation and caspase-8 activation,
whereas TNFRSF1B signals survival via complex I and NF-κB
activation. Furthermore, we were able to establish a TNFRSF1A
apoptotic program that involved caspase-8, caspase-2 and P53, but
bypassed caspase-3. The molecular mechanism proposed applies
not only for the zebrafish because activation of TNFRSF1A also
promoted apoptosis and caspase-2 and P53 activation in human
endothelial cells following TNFα treatment. This evolutionarily
conserved apoptotic pathway involved in vascular development and
homeostasis places TNFRs and caspase-2 in the front line for
inflammatory, angiogenesis and tumor drug development.
RESULTS
Genetic depletion of TNFRSF1B results in blood circulation
disruption, blood pooling and vascular hemorrhage
The zebrafish has single orthologs of mammalian TNFRSF1A and
TNFRSF1B, which showed 38% amino acid similarity to their
human counterparts and conserved TNFR superfamily and death
domains (Grayfer and Belosevic, 2009). In addition, we confirmed
by pull-down assay that TNFα was able to bind both TNFRs
(supplementary material Fig. S1). Gene expression analysis by
quantitative real-time reverse transcriptase polymerase chain
reaction (RT-qPCR) showed that the mRNA of both TNFRs was
present in zebrafish embryos at spawning, indicating that it was
maternally transferred (supplementary material Fig. S2A). However,
the expression profiles of genes encoding the two TNRFs were
different: whereas the mRNA levels for TNFRSF1A drastically
increased 24 hours post-fertilization (hpf) and reached a plateau,
those for TNFRSF1B peaked at 4 hpf, strongly decreased at 7 hpf
and then remained low. In situ hybridization corroborated RT-
qPCR analyses and, additionally, showed that both TNFRs were
ubiquitously expressed in zebrafish embryos (supplementary
material Fig. S2B). In addition, mRNA for TNFα was first detected
24 hpf and increased after 72 hpf (supplementary material Fig. S2A),
suggesting that other ligands beside TNFα might be signaling
through these receptors early in development. Lymphotoxin α
(LTα), which is able to bind both TNFRs in mammals (Schneider
et al., 2004), would be a plausible candidate for signaling through
TNFRs in early embryos because it was found to be expressed and
peaked as early as 7 hpf (supplementary material Fig. S2A).
In zebrafish, one important intra-embryonic primitive
hematopoiesis site is conformed by the intermediate cell mass
(ICM), equivalent to the mammalian yolk sac blood island and
located in the trunk ventral to the notochord. Subsequently, the
definitive hematopoietic stem cells emerge from the ventral wall
of the dorsal aorta and then migrate to the posterior region in the
tail called the caudal hematopoietic tissue (CHT). Hematopoiesis
starts at around 18 hpf in the ICM, where cells within this site
differentiate into the endothelial cells of the trunk vasculature and
proerythroblasts, which begin to enter the circulation at around
24 hpf (de Jong and Zon, 2005; Paik and Zon, 2010). Initially, one
unique dorsal vessel is formed that will generate the dorsal aorta
(DA) and caudal artery (CA). By sprouting of cells from the DA,
intersegmental primary vessels (IPVs) appear anterior, and the
posterior cardinal vein (PCV) and caudal vein (CV) appear
posterior (Isogai et al., 2001). During a second dorsal sprouting
from the PCV and CV, the functional fate of the IPVs of the primary
vascular network varies according to whether or not a functional
connection is made to a secondary sprout. Thus, approximately
half of the IPVs eventually become part of intersegmental veins
(ISVs), whereas the remainders give rise to intersegmental arteries
(ISAs) (Isogai et al., 2001) (Fig. 1A).
Depletion of TNFRSF1B by a morpholino (MO) antisense
oligonucleotide targeting the intron-1–exon-2 boundary of pre-
mRNA (supplementary material Fig. S3 and Table S1) resulted in
viable zebrafish for up to 7 days post-fertilization (dpf) with no
obvious developmental delay (supplementary material Table S2).
However, less than 5% of fish in all experiments showed altered
head development, delayed yolk reabsorption and pericardial
edema at 54 and 72 hpf compared with fish injected with a
standard control MO (Fig. 1B,C). Analysis of double transgenic
fli1a:eGFP/gata1:dsRed fish to visualize in vivo blood vessel
formation (endothelial cells stained green) and circulation
(erythrocytes stained red) revealed that TNFRSF1B depletion
resulted in the absence of blood circulation and erythrocyte
accumulation within the DA and CA at 54 hpf (Fig. 1B) and the
appearance of large hemorrhages throughout the body, blood
pooling and aberrant CV formation at 72 hpf (Fig. 1C-F). Although
IPV formation was largely unaffected, abnormal non-functional and
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TRANSLATIONAL IMPACT
Clinical issue
Tumor necrosis factor-a (TNFa) is a powerful pro-inflammatory cytokine that
plays a prominent pathogenic role in many human diseases, including
inflammatory and autoimmune disorders, ischemia-reperfusion injury and
cancer. Although it is well known that TNFa signals through the receptors
TNFRSF1A and TNFRSF1B, there are still outstanding questions about the
signaling pathways associated with each receptor, and how each receptor
contributes to the development of diseases is still largely unknown. 
Results
This paper addresses this issue using the zebrafish embryo as a model system.
The authors show that genetic depletion of TNFRSF1B in zebrafish embryos
results in the induction of an apoptotic program in endothelial cells that
requires caspase-8, caspase-2 and P53, but that bypasses caspase-3.
Simultaneous depletion of TNFRSF1A, or activation of nuclear factor-κB (NF-
κB), rescues endothelial cell apoptosis, indicating that a balance of signaling
mediated by both receptors is required for endothelial cell integrity. Thus,
TNFRSF1A triggers apoptosis via caspase-8, whereas TNFRSF1B promotes
survival via NF-κB. Importantly, this apoptotic pathway seems to be
evolutionarily conserved, as TNFa promotes apoptosis of human endothelial
cells and triggers caspase-2 and P53 activation in these cells via TNFRSF1A. 
Implications and future directions
Several systemic inhibitors of TNFa, such as soluble TNFa receptors and TNFα
antibodies, have been approved for the treatment of human diseases in which
TNFα plays a pathogenic role. However, these drugs have severe side effects
and are expensive. Hence, new active blockers of TNFa that are safe,
efficacious and inexpensive are urgently needed. The crucial balance of
signaling between TNFRSF1A and TNFRSF1B identified in this study suggests
that drugs specifically targeting TNFa receptors and their signaling adaptor
molecules, rather than TNFa, could be developed to treat TNFa-driven human
diseases.
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Fig. 1. Genetic depletion of TNFRSF1B results in endothelial cell apoptosis and blood circulation disruption. (A)Scheme showing the main vessels of a 3-
day-old zebrafish larvae. (B-G)Lateral view of 54 (B) and 72 (C-F) hpf and tranverse and sagittal sections (G, bottom panels) of double transgenic fli1a:eGFP and
gata1:dsRed larvae microinjected at the one-cell stage with standard control (STD-mo) and TNFRSF1B MOs. (B)TNFRSF1B depletion results in impaired
differentiation of the CA and CV during the first sprouting, leading to blood pooling (bp) inside an enlarged unique dorsal vessel (asterisk). (C,D)At 72 hpf, blood
pooling can still be observed in the caudal body part. In addition, hemorrhages appear throughout the body (arrowheads). (E,F)Zoomed views of trunk
vasculature of 72 hpf larvae. TNFRSF1B deficiency results in the alteration of the second sprouting leading to the formation of a net of vessels that replace the CA
and CV (E,F) and altered development of ISV (E). Arrows indicate ISA without blood circulation. (G,H)Confocal Z-stack sections of whole larvae (G) and sections
(H) of the CHT of 60 hpf Tg(fli1a:eGFP) injected with standard and TNFRSF1B MOs showing TUNEL-positive cells (red) (arrowheads). Nuclei were counterstained
with DAPI (blue). (I)Quantification of TUNEL-positive non-endothelial cells (eGFP−) and endothelial cells (eGFP+) at 60 hpf from serial Z-stack sections. Each dot
represents the number of TUNEL-positive cells per single larvae. The mean ± s.e.m. of the TUNEL-positive cells for each group of larvae is also shown; ***P<0.001.
Scale bars: 100 μm unless otherwise indicated. CA, caudal artery; CV, caudal vein; CHT, caudal haematopoietic tissue; DA, dorsal aorta; DLAV, dorsal longitudinal
anastomotic vessel; IPV, intersegmental primary vessels; ISV, intersegmental vessels; PCV, posterior cardinal vein; SIV, subintestinal vessels.
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bypassed ISVs and ISAs were observed (Fig. 1E). These defects
resulted in a caudal vessel net with or without blood circulation
(Fig. 1F). In addition, we found increased numbers of TUNEL-
positive endothelial cells in TNFRSF1B-deficient embryos, whereas
there were no statistically significant differences in the numbers of
TUNEL-positive non-endothelial cells between control and
TNFRSF1B-deficient larvae (Fig. 1G,H). These results suggest that
apoptosis of endothelial cells was largely responsible for the
vascular defects triggered by TNFRSF1B depletion.
The vascular defects observed in TNFRSF1B-deficient larvae
were also found with two additional MOs (supplementary material
Table S1), which targeted the exon-1–intron-1 boundary and the
ATG–5′UTR (supplementary material Fig. S4). The defects were
also rescued by the overexpression of wild-type TNFRSF1B mRNA
but not by antisense TNFRSF1B mRNA (Fig. 2A). In addition, to
further confirm the specificity of these MOs, we generated a
dominant-negative mutant of TNFRSF1B (DN TNFRSF1B) and
expressed the mRNA in embryos. DN TNFRSF1B lacks the entire
intracellular signaling domain, but is identical to full-length
TNFRSF1B in its transmembrane and extracellular domains.
Trimerization of DN TNFRSF1B with endogenous TNFRSF1B is
expected to extinguish TNFRSF1B signaling (Fang et al., 2008).
Hence, it was found that overexpression of the mRNA of DN
TNFRSF1B resulted in similar vascular defects; although the
phenotype was less penetrating and hemorrhages were less frequent
(supplementary material Fig. S5). Strikingly, although TNFRSF1A
knockdown (supplementary material Fig. S3) had no effect on
vascular development, it was able to rescue the vascular defect
observed in TNFRSF1B-deficient embryos (Fig. 2B), further
confirming the specificity of the MOs used.
Pharmacological and genetic manipulation of NF-κB has shown
that NF-κB signaling via TNFRs is involved in endothelial cell
survival (Santoro et al., 2007), therefore we overexpressed NEMO,
which is the regulatory subunit of the IκB kinase and is required
for NF-κB activation. NEMO was able to rescue in a dose-
dependent manner the wild-type vascular phenotype in
TNFRSF1B-deficient fish (Fig. 2C). Notably, TNFRSF1B deficiency
also resulted in the induction of TNFRSF1A and TNFα gene
expression, which was fully rescued by the depletion of TNFRSF1A
(Fig. 2D). These results suggest that the depletion of TNFRSF1B
results in an imbalance between TNFRSF1A and TNFRSF1B
signaling, which, in turn, results in the activation of an apoptotic
pathway through TNFRSF1A, leading to endothelial cell death,
vasculature disruption and/or hemorrhages.
TNFRSF1B depletion triggers a caspase-8 apoptotic pathway via
TNFRSF1A in endothelial cells
Because caspase-8 is the main initiator caspase involved in TNFR
signaling, we analyzed caspase-8 activity in TNFRSF1B-deficient fish.
Fig. 3A shows that the depletion of TNFRSF1B not only increased
caspase-8 activity, but also increased that of caspase-9, an initiator
caspase of the intrinsic apoptotic pathway that is usually activated
following mitochondrion architecture demolition (Taylor et al.,
2008). Genetic depletion of caspase-8 with specific MOs (Sidi et al.,
2008) and the inhibition of caspase-8 by overexpression of the mRNA
of the specific inhibitors CASP8 and FADD-like apoptosis regulator
(CFLAR) and cytokine response modifier A (CRMA), which are
zebrafish endogenous and cowpox virus caspase-8 inhibitors,
respectively, resulted in a partial rescue of the vascular defect
promoted by TNFRSF1B deficiency (Fig. 3B,C). However, caspase-
9 depletion was unable to rescue the vascular defect of TNFRSF1B-
deficient embryos (Fig. 3D). As the caspase-9 MO is not 100%
efficient (Sidi et al., 2008), we cannot rule out an involvement of
caspase-9 in the vascular defects observed in the TNFRSF1B
morphant. Collectively, these data suggest the activation of an
apoptotic pathway, initiated by caspase-8 via TNFRSF1A, that
promotes endothelial cell apoptosis in the absence of NF-κB-
dependent survival signals provided by TNFRSF1B activation.
P53 activation is indispensable for promoting caspase-8-
dependent apoptosis of endothelial cells in TNFRSF1B-deficient
zebrafish embryos
The activation of caspase-9 in TNFRSF1B-deficient embryos led
us to look more closely at the contribution of the intrinsic apoptotic
pathway in vascular development and maintenance. We observed
the induction of P53 at both mRNA (Fig. 4A) and protein (Fig. 4B,C)
levels in TNFRSF1B-deficient zebrafish. Strikingly, P53 was mainly
induced in endothelial cells (Fig. 4C), which further suggests that
TNFR signaling plays a crucial role in vascular development.
Furthermore, the induction of P53 observed in TNFRSF1B-
deficient embryos was strongly reduced in embryos deficient in
both TNFRSF1A and TNFRSF1B. The induction was caspase-8-
dependent because genetic depletion of caspase-8 largely attenuated
P53 induction (Fig. 4A). Finally, the activation of P53 was also
confirmed by the sharp upregulation of the P53-dependent genes
encoding BAX and MDM2 (Fig. 4D) and P21 (Fig. 4E) in
TNFRSF1B-deficient embryos.
To clarify the importance of P53 induction and activation in
vascular integrity, we depleted P53 by using a specific MO
(Langheinrich et al., 2002) and used the P53 zebrafish mutant line
P53M214K (Berghmans et al., 2005). We found that the P53 MO
almost completely rescued the vascular defects of TNFRSF1B-
deficient embryos (Fig. 4F) and abrogated the induction of caspase-
8 gene expression (Fig. 4G). Similarly, the P53M214K mutant
embryos did not show significant vascular alteration (data not
shown) and P21 and caspase-8 gene expression was unaltered (Fig.
4H) following genetic depletion of TNFRSF1B. Strikingly, however,
TNFRSF1B deficiency in this line resulted in caspase-8 activation,
although caspase-9 activity was unaltered (Fig. 3A). Collectively,
these results suggest the re-amplification of TNFRSF1A-dependent
apoptosis of endothelial cells by a crosstalk between extrinsic
(caspase-8) and intrinsic (P53) apoptotic pathways (Fig. 4I).
DNA fragmentation in endothelial cells triggers P53 activation in
TNFRSF1B-deficient zebrafish
Because caspase-activated deoxyribonuclease (CAD) is an
endonuclease that is activated once caspases cleave its inhibitor
(ICAD) and because TNFRSF1B depletion results in DNA
fragmentation in endothelial cells, we overexpressed zebrafish
ICAD in TNFRSF1B-deficient embryos. We found that ICAD
overexpression rescued the vascular defects of TNFRSF1B-deficient
embryos in a dose-dependent manner (Fig. 5A) and reduced (by
about 25%) the induction of caspase-8 and P53 (data not shown).
We next asked whether the checkpoint kinase CHK1 might be
involved in the activation of P53 following CAD-mediated DNA
damage. To inhibit CHK1, we used the indolocarbazole small
dmm.biologists.org386
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molecule Gö6976, which has a high specificity for CHK1 and has
been successfully used in whole zebrafish embryos (Sidi et al., 2008).
Genetic depletion of P53 failed to rescue the vascular defects of
TNFRSF1B-deficient embryos in the presence of Gö6976 (Fig. 5B),
suggesting that CHK1 might be downstream of P53 in this apoptotic
signaling pathway triggered by TNFRSF1A in endothelial cells.
TNFRSF1A apoptotic signaling pathway is independent of
caspase-3 but requires caspase-2
To identify the executor caspase linking the TNFRSF1A–caspase-
8 and CAD–P53 axis, we analyzed the activation of caspase-3,
which is a hallmark of both extrinsic and intrinsic apoptotic
pathways. Interestingly, although TNFRSF1B depletion resulted in
increased numbers of apoptotic endothelial cells in the CHT (Fig.
1I,J), it failed to significantly increase active caspase-3 levels in
endothelial cells compared with control embryos (injected with a
standard MO) (Fig. 6A). Because CAD is involved in the
TNFRSF1A apoptotic signaling pathway of zebrafish endothelial
cells, we studied the involvement of caspase-2, which has been
shown to process ICAD (Dahal et al., 2007) and is involved in an
apoptotic response to DNA damage that bypasses caspase-3 (Sidi
et al., 2008). We found that caspase-2 is activated in TNFRSF1B-
deficient embryos and seems to be placed downstream of caspase-
8 because genetic depletion of caspase-8 reduced caspase-2
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Fig. 2. A crucial balance between TNFRSF1A and TNFRSF1B signaling is required for endothelial cell development and maintenance. (A-D)Zebrafish
embryos were microinjected at the one-cell stage with standard (STD-mo) and TNFRSF1B MOs alone or in combination with the indicated mRNAs. At 72 hpf, the
vascular defects were scored. Larvae revealing no defects were scored as wild type (white), larvae showing erythrocyte accumulation in the CHT, partial blood
circulation and hemorrhages were scored as mildly affected (gray) and larvae displaying erythrocyte accumulation in the CHT and no blood circulation as
severely affected (black). (A)Effect of wild-type and antisense TNFRSF1B mRNA overexpression in morphant embryos. Note that wild-type, but not antisense
TNFRSF1B mRNA partially rescues the TNFRSF1B morphant phenotype (B) Partial rescue of the vascular defect promoted by genetic depletion of TNFRSF1B by
TNFRSF1A depletion. (C)NEMO-mediated activation of NF-κB partially rescues the vascular defect promoted by genetic depletion of TNFRSF1B. (D)mRNA
quantification of the indicated genes were determined by real-time RT-PCR in 10 pooled larvae. The gene expression is normalized against rps11 and are
representative of two independent experiments. Each bar represents the mean + s.e.m.; *P<0.05, **P<0.01, ***P<0.0001; n.s., not significant according to Chi-
square contingency (A-C) or Student’s t-tests (D).
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activation in TNFRSF1B-deficient animals (Fig. 6B). To corroborate
the relevance of caspase-2 activation in endothelial cell apoptosis,
we ablated caspase-2 using a specific MO (Sidi et al., 2008). The
results showed that caspase-2 deficiency was able to partially rescue
the vascular defects of TNFRSF1B-deficient embryos (Fig. 6C).
Caspase-2–P53 apoptotic signaling pathway triggered by
TNFRSF1A is evolutionarily conserved
We next wondered whether this new signaling pathway also
operates in human endothelial cells. We first confirmed by RT-
PCR that primary human umbilical vein endothelial cells
(HUVECs) expressed both TNFRs (data not shown). Treatment
of primary HUVECs with recombinant TNFα resulted in the
induction of apoptosis in a small proportion of cells (ranging from
10-20%) (Fig. 7A-C), whereas the neutralization of TNFRSF1B
with a specific antibody slightly increased the percentage of cells
undergoing apoptosis in response to TNFα (Fig. 7A). More
importantly, the numbers of caspase-2-positive cells significantly
increased (Fig. 7B), whereas caspase-3 levels hardly increased
following treatment of the cells with a TNFα mutein that
dmm.biologists.org388
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Fig. 3. TNFRSF1B depletion promotes a caspase-8 apoptotic pathway via TNFRSF1A in endothelial cells. (A-D)Wild-type and P53M214K zebrafish embryos
were microinjected at the one-cell stage with standard, TNFRSF1A, TNFRSF1B, P53, CASP8 and CASP9 MOs alone or in combination with the mRNAs encoding
the caspase-8 inhibitors CFLAR and CMRA. (A)The activation of caspase-8 and caspase-9 in whole embryos was quantified at 60 hpf using the luminescent assays
Caspase-Glo 8 and Caspase-Glo 9. Represented are mean values + s.e.m. (B-D)Vascular defects scored at 72 hpf as indicated in the legend to Fig. 2. Different
letters denote statistically significant differences among the groups according to a Tukey test. Note that inhibition of the caspase-8 but not caspase-9 pathway
partially rescues the TNFRSF1B vascular phenotype. *P<0.05, **P<0.01, ***P<0.0001; n.s., not significant according to a Chi-square contingency test (B-D).
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specifically interacts with TNFRSF1A (Fig. 7D). In addition,
levels of mRNAs encoding P21 and P53 also increased following
treatment with TNFα mutein (Fig. 7E) and, notably,
pharmacological inhibition of CHK1 with Gö6976 resulted in a
further upregulation of P53 and P21 gene expression (Fig. 7E)
and accumulation of P53 protein (Fig. 7F). These results suggest
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Fig. 4. P53 activation is indispensable for promoting caspase-8-dependent apoptosis of endothelial cell in TNFRSF1B-deficient zebrafish. (A-H)Wild-
type (A,B,D-G), transgenic fli1a:eGFP (C) and P53M214K (H) zebrafish embryos were microinjected at the one-cell stage with standard, TNFRSF1A, TNFRSF1B and
P53 MOs. At 72 hpf, the mRNA levels of the indicated genes were determined by real-time RT-PCR in 10 pooled larvae (A,D,E,G,H). The gene expression is
normalized against rps11, each bar represents the mean + s.e.m. Different letters denote statistically significant differences among the groups according to a
Tukey test. *P<0.05; n.s., not significant according to Chi-square contingency (F) or Student’s t tests (D,E,H). (A)Co-injection of TNFRSF1A or CASP8 MOs reduces
TNFRSF1B-MO-mediated P53 upregulation. (B)P53 protein levels were assayed by western blot in dechorionated and deyolked embryos at 24 hpf. Note that P53
levels are upregulated in TNFRSF1B-deficient larvae. (C)Whole mount immunohistochemistry against P53 at 3 dpf in Tg(fli1a:eGFP) larvae injected with standard
or TNFRSF1B MOs. Note a massive increase in P53 expression (red) in the vascular endothelium (green) of TNFRSF1B-deficient larvae. (D,E)TNFRSF1B silencing
leads to upregulation of bax, mdm2 and p21. (F)Vascular defects in larvae deficient in both TNFRSF1B and P53 were scored as indicated in the legend to Fig. 2.
Note that P53 deficiency partially rescues the vascular defects observed in TNFRSF1B-deficient fish. (G)Upregulation of caspase-8 by TNFRSF1B deficiency is
dependent on TNFRSF1A and P53. (H)p21 mRNA levels in P53 mutant larvae are not altered by TNFRSF1B silencing. (I)Representation of the proposed
amplification loop between extrinsic and intrinsic apoptotic pathways triggered by TNFRSF1A. CA, caudal artery; CV, caudal vein; ISV, intersegmental vessels.
Scale bars: 25 μm.
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that this kinase is involved in a P53- and P21-dependent cell cycle
arrest triggered by TNFRSF1A in endothelial cells.
DISCUSSION
Tight molecular control of endothelial cell survival, integrity and
apoptosis is essential for both embryonic and adult angiogenesis.
Santoro and coworkers recently showed that the anti-apoptotic
adaptor protein BIRC2 plays an essential role in regulating
endothelial cell survival in vivo (Santoro et al., 2007). However,
because BIRC2 is known to be involved in the signaling pathways
of several death receptors, including FAS (Ruemmele et al., 2002),
CD40 (Bureau et al., 2002; Fotin-Mleczek et al., 2002), TNFRSF1A
(Shu et al., 1996) and TNFRSF1B (Rothe et al., 1995), the nature
of the receptor(s) involved in vascular development and integrity
remains unclear. Using a gain- and loss-of-function approach, we
found that the TNFRSF1A and TNFRSF1B signaling pathways must
be balanced for endothelial cell development to be maintained in
zebrafish. Furthermore, in endothelial cells, TNFRSF1A signals
apoptosis through complex II and caspase-8, whereas TNFRSF1B
signals survival via complex I and NF-κB. A similar crosstalk
between TNFRSF1A and TNFRSF1B signaling pathways has also
been observed in human aortic endothelial cells, whose
susceptibility to TNFα treatment can be rescued by blocking
TNFRSF1A or NF-κB (Okada et al., 2001). These results, together
with the ability of TNFRSF1B to induce the depletion of TRAF2
and BIRC2 proteins and accelerate the TNFRSF1A-dependent
activation of caspase-8 (Fotin-Mleczek et al., 2002), suggest that
BIRC2 is required for TNFRSF1B complex I formation and NF-κB
activation in endothelial cells, despite the high promiscuity of this
adaptor molecule.
One of the most interesting observations made in our study is
that the TNFRSF1A-dependent apoptotic pathway of endothelial
cells is independent of caspase-3 and caspase-9, but requires
caspase-2, an enigmatic caspase that possesses both initiator and
executioner caspase characteristics (Krumschnabel et al., 2009).
Our in vivo epistasis analysis led us to envisage a model whereby
TNFRSF1A engagement leads to the following sequential events
(Fig. 8): (i) activation of caspase-8, (ii) activation of caspase-2, (iii)
processing of ICAD by caspase-2 and translocation of CAD to the
nucleus, (iv) activation of P53, and (v) P53-dependent induction of
caspase-8 gene expression. As human caspase-2 has been shown
to cleave ICAD in vitro (Dahal et al., 2007), we hypothesised that
caspase-2 would replace caspase-3 as the main executor caspase
and would mediate the cleavage of ICAD and the subsequent
activation of P53. In fact, we observed that P53 was firmly involved
in the TNFRSF1A-mediated apoptosis of endothelial cells.
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Fig. 5. DNA fragmentation in endothelial cells
triggers P53 activation in TNFRSF1B-deficient
zebrafish. (A,B)Wild-type zebrafish embryos were
microinjected at the one-cell stage with standard
and/or TNFRSF1B MOs alone or in combination with
the mRNAs encoding ICAD or the antisense mRNA for
TNFRSF1B, as an appropriate control. Some larvae
were treated at 48 hpf by bath immersion for 16
hours with 1 μM of the CHK1 specific inhibitor
Gö6976. Vascular defects were scored at 72 hpf as
indicated in the legend to Fig. 2. *P<0.05, **P<0.01,
***P<0.0001; n.s., not significant according to a Chi-
square contingency test.
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Furthermore, P53 might also be involved in the direct activation
of caspase-2 in TNFRSF1B-deficient endothelial cells, as indicated
by recent findings that that caspase-2 is involved in a P53-positive
feedback loop during DNA damage response (Oliver et al., 2011).
Thus, caspase-2 cleaves MDM2, promoting P53 stability, which
leads to the transcription of PIDD, a P53 target gene product that
activates caspase-2 in a complex called the caspase-2–PIDDosome.
Regardless of the mechanism, the apoptotic program triggered by
TNFRSF1A in endothelial cells involves a positive regulatory
feedback between the intrinsic and extrinsic apoptotic pathways,
which ends in the upregulation of caspase-8, further contributing
to the apoptosis of endothelial cells. To the best of our knowledge,
this observation has not previously been reported in vivo but it is
not unexpected because P53 has also been found to be able to
upregulate caspase-8 gene transcription in human cancer cells
treated with cytotoxic drugs (Ehrhardt et al., 2008).
The inhibition of the cell cycle checkpoint kinase CHK1, which
is activated by ATR in response to replication stress (Cuadrado et
al., 2006), impairs the ability of P53 knockdown to rescue the
vascular defect promoted by TNFRSF1A in zebrafish embryos and
further induces the expression of P21 in TNFα-treated HUVECs,
indicating that CHK1 might be downstream of P53 in the apoptotic
signaling pathway triggered by TNFRSF1A in endothelial cells or,
alternatively, it might inhibit a P53-independent apoptotic pathway
in these cells. This is not unexpected because a role for CHK1 has
recently been described in the inhibition of an ATM/ATR–caspase-
2 apoptotic response to irradiation-induced DNA damage that
bypasses P53 and caspase-3 (Sidi et al., 2008). Although the CHK1-
dependent and P53-independent apoptotic pathway triggered by
TNFRSF1A deserves further investigation, our results also suggest
that CHK2 mediates activation of P53 in TNFRSF1B-deficient
endothelial cells.
Although several systemic inhibitors of TNFα, such as soluble
TNF receptors and anti-TNFα antibodies, have been approved for
the treatment of human diseases where TNFα plays a pathogenic
role, these drugs exhibit severe side effects and are expensive.
Hence, new active blockers of TNFα that are safe, efficacious and
inexpensive are urgently needed (Sethi et al., 2009). We believe that
the TNFRSF1A apoptotic axis described in this study reveals new
molecular targets for the development of therapeutic drugs for
human diseases where TNFα plays a major role, such as
inflammatory and autoimmune disorders, ischemia-reperfusion
injury and cancer. The TNFα-induced caspase-2–P53 apoptotic
program in HUVECs, the vascular defects of TNFRSF1A-deficient
zebrafish and the recent observations in transgenic mice
overexpressing TNFRSF1B in endothelial cells showing decreased
death of these cells after ischemia-reperfusion and higher
endothelial cell proliferation, neovascularization and vessel
maturation after injury (Luo et al., 2010), strongly suggest that
TNFRSF1A and TNFRSF1B, rather than TNFα, might be the better
clinical targets.
In conclusion, we have identified an evolutionarily conserved
apoptotic program in endothelial cells that is triggered by the
imbalance between survival and death signals provided by TNFRs.
This pathway involves crosstalk between intrinsic (caspase-8) and
extrinsic (P53) apoptotic programs but, intriguingly, bypasses
caspase-3. Caspase-2 replaces caspase-3 and links both apoptotic
programs, probably due to its dual activity as initiator and
executor caspase. This genetic pathway reveals new therapeutic
targets for the control of inflammation- and tumor-induced
angiogenesis.
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Fig. 6. The TNFRSF1A apoptotic signaling pathway of endothelial cells is
independent of caspase-3 but requires caspase-2. (A-C)Wild-type and
transgenic fli1a:eGFP zebrafish embryos were microinjected at the one-cell
stage with standard, TNFRSF1B, CASP8 and/or CASP2 MOs. (A)The activation
of caspase-3 in embryos was quantified at 60 hpf by flow cytometry using a
specific antibody for active caspase-3. (B)Caspase-2 levels were determined
using the luminescent assay Caspase-Glo 2. (C)Vascular defects were also
scored at 72 h.p.f. as indicated in the legend to Fig. 2. Note that TNFRSF1B
depletion resulted in the caspase-8 dependent activation of caspase-2 and
that caspase-2 depletion rescued the vascular defects of TNR2-deficient fish.
Some larvae were treated at 48 hpf by bath immersion for 16 hours with 0.5
μM camptothecin (campt) or 0.5 μM staurosporine (Stauros) in the presence or
absence of 100 μM of the caspase-3 inhibitor Ac-DEVD-CHO, as appropriate
controls for caspase activation. Different letters denote statistically significant
differences between the groups according to a Tukey test; *P<0.05,
***P<0.0001; n.s., not significant, according to Student’s t-test (A) and Chi-
square contingency test (C).
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MATERIALS AND METHODS
Animals
Wild-type zebrafish (Danio rerio H. Cypriniformes, Cyprinidae)
were obtained from the Zebrafish International Resource Center
(ZIRC) and maintained as described in the zebrafish handbook
(Westerfield, 2000). The transgenic zebrafish line that expresses
enhanced GFP (eGFP) driven by the endothelial cell-specific
promoter fli1a gene Tg(fli1a:egfp)y1 (Lawson and Weinstein, 2002)
was obtained from ZIRC. The transgenic line with red fluorescent
erythrocytes Tg(gata1:dsRed)sd2 (Traver et al., 2003) and the P53
mutant line zdf1 (P53M214K) (Berghmans et al., 2005) were kindly
provided by Leonard I. Zon (HSCRB, Harvard University,
Cambridge, MA). The experiments described comply with the
Guidelines of the European Union Council (86/609/EU) and of the
Bioethical Committee of the University of Murcia (approval number
#333/2008) for the use of laboratory animals.
Embryos and larvae were anesthetized in Tricaine (200 μg/ml)
and examined using a Leica MZ16FA stereomicroscope. The
vascular defects were scored semiquantitatively in blind samples
at 48 and 72 hpf as wild type (no defects), mildly affected
(erythrocyte accumulation in the CHT, partial blood circulation
and hemorrhages) and severely affected (erythrocyte accumulation
in the CHT and no blood circulation).
Morpholinos, mRNA microinjection and chemical treatment
Splice- or translation-blocking MOs were designed by and
purchased from Gene Tools and solubilized in water (1-3 mM)
(supplementary material Table S1). All eggs were injected with the
same amount of MOs. Full-length TNFRSF1A (BC068424),
TNFRSF1B (ENSDARG00000070165) and ICAD
(NM_001002631), and DN TNFRSF1B (amino acids 1-162) were
subcloned into the pCS2+ or pBluescript II KS+ vectors. NEMO
and CFLAR in a PCS2 backbone were provided by Massimo
Santoro (University of Turin, Turin, Italy) (Santoro et al., 2007).
CMRA construct was obtained from the BCCM/LMBP plasmid
collection (Ghent University, Belgium).
mRNA was synthesized using the mMESSAGE MACHINE kit
(Ambion) and polyadenylated using a polyadenylation kit
(Ambion) according to the manufacturer’s instructions. mRNA
(0.5-1 ng/egg) and MOs (1-5 ng/egg) were mixed in microinjection
buffer (0.5× Tango buffer and 0.05% phenol red solution) and
microinjected (0.5-1 nl) into the yolk sac of one-cell-stage embryos
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Fig. 7. The caspase-2–P53 apoptotic signaling
pathway triggered by TNFRSF1A is
evolutionarily conserved. (A-F)HUVEC were
treated for 16 hours with 40 ng/ml human TNFα
(hTNFα) alone or in combination with 5 μg/ml of a
mouse IgG isotype control or a neutralizing
antibody to human TNFRSF1B (αhTNFRSF1B) (A,E)
or with a TNFα mutein specific for TNFRSF1A 
(B-D,F). (A) Cell viability was determined using the
MTT colorimetric assay. (B,C)PS flip and caspase-2
activity were evaluated by flow cytometry and
immunofluorescence using phycoerythrin-Annexin
V conjugate and the CaspGLOW Fluorescein Active
Caspase-2 Staining kit, respectively. Note that
Annexin V+ cells showed membrane blebbing (C,
arrowheads). BF, bright field. (D)Caspase-3
activation was determined by immunofluorescence
using a specific antibody to active caspase-3. Some
cultures were treated for 16 hours with 0.5 μM
camptothecin (campt), 1 μM Gö6976 or 0.5 μM
staurosporine in the presence or absence of 50 μM
of the caspase-3 inhibitor Ac-DEVD-CHO. (E)mRNA
levels of the indicated genes were determined by
real-time RT-PCR, normalized against rps11, and
shown relative to non-treated cells (mean + s.e.m.).
(F)P53 protein levels were assayed by western blot
using monoclonal antibodies to human P53 (TP53)
and β-actin (ACTB). Different letters denote
statistically significant differences between the
groups according to a Tukey test. The groups
labeled with ‘a’ or ‘A’ in E were not statistically
significant from non-treated cells. *P<0.05
according to a Student’s t-test; ND, not determined.
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using a Narishige IM300 microinjector. Knockdown efficiencies
of TNFRSF1A and TNFRSF1B MOs are shown in supplementary
material Fig S2.
In some experiments, 24-hpf embryos were dechorionated and
transferred to fresh E3 medium containing 1% DMSO, with or
without the CHK1 inhibitor Gö6976 (1 μM; Calbiochem) (Sidi et
al., 2008).
Analysis of development
The effect of MOs on development was evaluated as previously
reported (Kimmel et al., 1995). Briefly, the side-to-side flexures were
recorded at 22 hpf (25-26 somites stage); heartbeat, red blood cells
on yolk and early pigmentation in retina and skin at 24 hpf (Prim
5 stage); head trunk angle (HTA), retina pigmented, early touch
reflect and straight tail at 30 hpf (Prim 15 stage); and early motility
and tail pigmentation at 36 hpf (Prim 25).
Determination of caspase activity
The activation of caspase-9, caspase-8 and caspase-2 in whole
embryos was quantified using the luminescent assays Caspase-Glo
9, Caspase-Glo 8 and Caspase-Glo 2 (Promega), respectively, as
described previously (Geiger et al., 2006). The substrate specificity
and sensitivity to pharmacological inhibitors of zebrafish caspase-8
and caspase-9 has been found to be similar to their mammalian
orthologs (Chen et al., 2001; Chiu et al., 2010; Friedrich et al., 2004;
Santoro et al., 2007; Stanton et al., 2006; Wrasidlo et al., 2008).
Caspase-3 activation was determined by flow cytometry using an
affinity-purified rabbit anti-human/mouse caspase-3 active (0.5
μg/ml; epitope CRGTELDCGIETD, #AF835, R&D Systems)
(Sepulcre et al., 2011). As appropriate controls, 56-hpf larvae were
treated for 16 hours with 0.5 μM camptothecin or staurosporine
(Sigma-Aldrich) in the presence or absence of the caspase-3-specific
inhibitor Ac-DEVD-CHO (100 μM; Sigma-Aldrich).
Analysis of gene expression
Total RNA, extracted as indicated above, was treated with DNase
I, amplification grade (1 unit/μg RNA; Invitrogen). SuperScript III
RNase H− ReverseTranscriptase (Invitrogen) was used to synthesize
the first strand of cDNA with an oligo-dT18 primer from 1 μg of
total RNA at 50°C for 50 minutes.
Real-time PCR was performed with an ABI PRISM 7500
instrument (Applied Biosystems) using SYBR Green PCR Core
Reagents (Applied Biosystems). Reaction mixtures were incubated
for 10 minutes at 95°C, followed by 40 cycles of 15 seconds at 95°C
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Fig. 8. Model of TNFR signaling in
endothelial cells. The TNFRSF1A apoptotic
and TNFRSF1B survival pathways, the main
elements involved, and the crosstalk between
extrinsic and intrinsic apoptotic programs.
TNFRL, TNFR ligands (TNFa and LTa).
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and 1 minute at 60°C, and finally by 15 seconds at 95°C, 1 minute
60°C and 15 seconds at 95°C. For each mRNA, gene expression
was normalized to the ribosomal protein S11 (rps11) content in
each sample using the Pfaffl method (Pfaffl, 2001). In all cases, the
PCR was performed with triplicate samples and repeated with at
least two independent samples. The primers used are shown in
supplementary material Table S3.
Whole-mount immunohistochemistry
Embryos and larvae were fixed for 2 hours in 4% paraformaldehyde
(PFA) at room temperature, dehydrated in methanol-PBS solutions
(25, 50, 75 and 100%, 5 minutes each) and stored in 100% methanol
at –20°C. For staining, they were rehydrated in 75, 50 and 25%
methanol-PBT (PBS and 0.1% Tween-20) solutions (5 minutes
each), washed three times for 5 minutes in de-ionized water
(dH2O), permeabilized in cold acetone for 10 minutes at −20°C,
washed again twice in dH2O (5 minutes each) and treated with
blocking solution (PDT; PBS containing 0.1% Tween-20, 1% DMSO,
5% FBS and 2 mg/ml BSA) for 2 hours at room temperature. After
blocking, embryos were incubated overnight at 4°C with 0.5 μg/ml
affinity-purified rabbit anti-human/mouse caspase-3 active or anti-
zebrafish P53 (1:200; #55915, AnaSpec) diluted in PDT, washed six
times in PDT (10 minutes each), incubated for 2 hours at room
temperature in PDT, incubated overnight at 4°C with a 1:1000
dilution in PDT of a phycoerythrin-conjugated secondary antibody
(Invitrogen), washed five times in PBT (5 minutes each) and finally
examined under a LEICA MZ16FA stereomicroscope.
In situ hybridization
Whole mount in situ hybridization was performed according to a
published method (Schulte-Merker et al., 1994) with minor
modifications. In situ hybridization on paraffin sections was based
on a protocol developed by Mallo and co-workers (Mallo et al.,
2000). Similar results were obtained with three different riboprobes
against TNFRSF1A (probe 1, +64 to + 572; probe 2, +666 to +1177;
full length probe, +64 to +1177) and TNFRSF1B (probe 1, +113 to
+667; probe 2, +678 to +1189; full length probe, +113 to +1189).
The primers used to amplify the probes are shown in
supplementary material Table S3.
Detection of apoptotic cell death by TUNEL labeling
After overnight fixation in 4% PFA at 4°C, embryos were washed
in PBT for five minutes and dehydrated in a graded methanol series
until reaching 100% methanol. After storage at −20°C they were
rehydrated gradually in PBT, washed twice for 10 minutes in PBT
and digested in proteinase K (Roche) solution in PBT (10 μg/μl) at
room temperature for 15 minutes. After two washes in PBT,
embryos were postfixed in 4% PFA for 20 minutes. Embryos were
washed again twice in PBT for 10 minutes each and endogenous
biotin was blocked using the Biotin Blocking Kit (Vector,
Burlingame, CA). Embryos were washed in PBT and put into
equilibration buffer (Roche) for 1 hour. Embryos were subsequently
incubated with the TdT reaction mix (Roche) overnight at 37°C.
Reaction was stopped with washes in equilibration buffer for 3
hours at 37°C followed by three washes in PBT at room
temperature. Strepavidine-Cy3 (Jackson Laboratories) was then
added for 1 hour at room temperature. For concomitant GFP
detection, embryos were incubated with anti-GFP antibody
(Clontech, Mountain View, CA) followed by Alexa-Fluor-488-
conjugated secondary antibody (Invitrogen). Embryos were washed
and mounted in Vectashield supplemented with DAPI (Vector).
Methanol-fixed embryos were also embedded in paraffin,
sectioned at 5 μm and processed as previously described (González-
Rosa et al., 2011).
Immunoprecipitation and western blot assays
The physical interaction between zebrafish TNFα and TNFRs was
analyzed by means of immunoprecipitation. Plasmid DNA was
prepared using the Midi-Prep procedure (Qiagen) and transfected
into HEK293 cells with LyoVec transfection reagent (Invivogen),
according to the manufacturer’s instructions. At 48 hours after
transfection, the cells were washed twice with PBS and lysed in
200 μl lysis buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1%
Triton X-100, 0.5% NP-40, and a 1:20 dilution of the protease
inhibitor cocktail P8340 from Sigma-Aldrich). Whole cell extracts
were then mixed and incubated overnight at 4°C before being
immunoprecipitated with the anti-V5 mAb (Invitrogen) and protein
G Sepharose (Sigma-Aldrich). After extensive washing with lysis
buffer, the resins were boiled in SDS sample buffer and the bound
proteins resolved on 12% SDS-PAGE and transferred for 50 minutes
at 200 mA to nitrocellulose membranes (BioRad). Blots were probed
with specific antibodies to V5 or Xpress (Invitrogen) and developed
with enhanced chemiluminescence (ECL) reagents (GE Healthcare)
according to the manufacturer’s protocol.
Extracts (10 μg) from dechorionated and deyolked embryos,
obtained as indicated above for HEK293 cells, were probed with a
50% dilution of the monoclonal antibody LLzp53-9E10, which is
specific to zebrafish P53 (MacInnes et al., 2008). Membranes were
then reprobed with a 1:5000 dilution of a commercial rabbit
antibody to histone 3 (#ab1791, Abcam) as an appropriate loading
control.
HUVEC culture and treatments
Primary human endothelial cells (HUVECs) were cultured in
appropriate media according to the manufacturer’s protocol
(Lonza). Cells were stimulated for 16 hours with 40 ng/ml
recombinant TNFα (Sigma-Aldrich) alone or in the presence of 5
μg/ml TNFRSF1B neutralizing antibody (#MAB226, R&D Systems)
or an isotype control (#MAB003, R&D Systems). Alternatively, a
TNFα mutein specific for TNFRSF1A (GenScript) was used
(Loetscher et al., 1993). In some experiments, cells were also treated
with 0.5 μM camptothecin, 1 μM Gö6976 or 0.25 μM staurosporine
(Sigma-Aldrich) for 16 hours in the presence or absence of 50 μM
of the caspase-3 inhibitor Ac-DEVD-CHO. Cell viability was
determined spectrophotometrically using an MTT-based test
(Mosmann, 1983). Caspase-2 activation was determined by flow
cytometry using the CaspGLOW Fluorescein Active Caspase-2
Staining Kit (Biovision) and the accompanying staining protocols.
Caspase-3 activation was determined by immunofluorescence as
indicated for zebrafish embryos. Phosphatidylserine exposure on
the extracellular leaflet of the membrane was determined by flow
cytometry using a phycoerythrin-Annexin V conjugate (ENZO Life
Sciences) according to the manufacturer’s instructions. Finally, P53
protein levels were evaluated by western blot using monoclonal
antibodies to human P53 (#P6749) and β-actin (#A5441) (both from
Sigma-Aldrich).
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Statistical analysis
All experiments were performed at least three times, unless
otherwise indicated. The total number of animals used is indicated
above each bar in the figures. Data were analyzed by Student’s t-
test, or ANOVA and a Tukey’s multiple range test to determine
the differences among groups. Statistical significance was defined
as P<0.05. The Chi-square contingency test was used to determine
the differences between vascular defects scores.
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